KOBO BIOTECH LIMITED (KOBO.BO)
INR 2.95
(-4.84%)
INR 2.95
(-4.84%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -40.71 Million INR | 0.01% |
| 2022 | -40.71 Million INR | 11.6% |
| 2021 | -46.06 Million INR | 18.29% |
| 2020 | -56.37 Million INR | 4.1% |
| 2019 | -58.78 Million INR | 4.35% |
| 2018 | -61.45 Million INR | 4.65% |
| 2017 | -64.44 Million INR | 4.97% |
| 2016 | -67.82 Million INR | -371.5% |
| 2015 | -14.38 Million INR | -83.36% |
| 2014 | -7.84 Million INR | -120.06% |
| 2013 | 39.1 Million INR | -93.39% |
| 2012 | 591.77 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -10.11 Million INR | 0.01% |
| 2023 Q1 | -10.12 Million INR | -0.97% |
| 2023 Q4 | -10.11 Million INR | 1.62% |
| 2023 Q3 | -10.27 Million INR | -0.79% |
| 2023 Q2 | -10.19 Million INR | -0.69% |
| 2023 FY | -40.71 Million INR | 0.01% |
| 2022 Q1 | -11.51 Million INR | 2.55% |
| 2022 FY | -40.71 Million INR | 11.6% |
| 2022 Q4 | -10.03 Million INR | 2.17% |
| 2022 Q3 | -10.25 Million INR | -14.89% |
| 2022 Q2 | -8.92 Million INR | 22.48% |
| 2021 Q4 | -11.81 Million INR | -13.21% |
| 2021 FY | -46.06 Million INR | 18.29% |
| 2021 Q3 | -10.43 Million INR | -1.34% |
| 2021 Q2 | -10.29 Million INR | 23.81% |
| 2021 Q1 | -13.51 Million INR | 2.73% |
| 2020 Q2 | - INR | 0.0% |
| 2020 Q4 | -13.89 Million INR | 0.0% |
| 2020 FY | -56.37 Million INR | 4.1% |
| 2020 Q1 | - INR | 100.0% |
| 2020 Q3 | - INR | 0.0% |
| 2019 Q4 | -100.00 INR | 0.0% |
| 2019 Q2 | - INR | 0.0% |
| 2019 FY | -58.78 Million INR | 4.35% |
| 2019 Q1 | - INR | 100.0% |
| 2019 Q3 | - INR | 0.0% |
| 2018 Q3 | - INR | 0.0% |
| 2018 Q2 | - INR | 0.0% |
| 2018 Q1 | - INR | 0.0% |
| 2018 FY | -61.45 Million INR | 4.65% |
| 2018 Q4 | -1110.00 INR | 0.0% |
| 2017 Q2 | - INR | 0.0% |
| 2017 Q3 | - INR | 0.0% |
| 2017 Q1 | - INR | 100.0% |
| 2017 FY | -64.44 Million INR | 4.97% |
| 2017 Q4 | - INR | 0.0% |
| 2016 Q1 | - INR | 100.0% |
| 2016 FY | -67.82 Million INR | -371.5% |
| 2016 Q4 | -120.00 INR | 0.0% |
| 2016 Q3 | - INR | 0.0% |
| 2016 Q2 | - INR | 0.0% |
| 2015 Q1 | 67.6 Million INR | 461.07% |
| 2015 Q2 | 86.31 Million INR | 27.68% |
| 2015 FY | -14.38 Million INR | -83.36% |
| 2015 Q4 | -26.58 Million INR | -945.71% |
| 2015 Q3 | 3.14 Million INR | -96.36% |
| 2014 Q1 | -2.66 Million INR | 0.0% |
| 2014 FY | -7.84 Million INR | -120.06% |
| 2014 Q3 | -1.1 Million INR | 68.79% |
| 2014 Q4 | 12.04 Million INR | 1193.38% |
| 2014 Q2 | -3.53 Million INR | -32.27% |
| 2013 FY | 39.1 Million INR | -93.39% |
| 2012 FY | 591.77 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sunil Healthcare Limited | 247.86 Million INR | 116.426% |
| ANG Lifesciences India Limited | 232.73 Million INR | 117.494% |
| BDH Industries Limited | 175.55 Million INR | 123.192% |
| Deccan Health Care Limited | 221.57 Million INR | 118.375% |
| DECIPHER LABS LIMITED | 331.34 Million INR | 112.288% |
| Gujarat Themis Biosyn Limited | 1.28 Billion INR | 103.175% |
| Hindustan Bio Sciences Limited | 3.14 Million INR | 1396.524% |
| Ishita Drugs and Industries Limited | 38.94 Million INR | 204.553% |
| Jenburkt Pharmaceuticals Limited | 1.1 Billion INR | 103.674% |
| KIMIA BIOSCIENCES LIMITED | 111.76 Million INR | 136.429% |
| MedPlus Health Services Limited | 12.33 Billion INR | 100.33% |
| Patidar Buildcon Limited | -26 Thousand INR | -156492.308% |
| Add-Shop E-Retail Limited | 224.09 Million INR | 118.168% |
| Bacil Pharma Limited | -19.95 Thousand INR | -203980.201% |
| Beryl Drugs Limited | 108.5 Million INR | 137.523% |
| Cian Healthcare Limited | 113.16 Million INR | 135.977% |
| Concord Drugs Limited | 116.7 Million INR | 134.887% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | 119.492% |
| Gujarat Terce Laboratories Limited | 141.4 Million INR | 128.792% |
| Sastasundar Ventures Limited | 1.19 Billion INR | 103.394% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | -9928.079% |
| Source Natural Foods and Herbal Supplements Limited | 66.01 Million INR | 161.677% |
| SUDARSHAN PHARMA INDUSTRIES LI | 361.76 Million INR | 111.254% |
| Syschem (India) Limited | 569.04 Million INR | 107.155% |
| Medi-Caps Limited | 68.09 Million INR | 159.793% |
| Parmax Pharma Limited | 99.31 Million INR | 140.994% |
| Smruthi Organics Limited | 324.76 Million INR | 112.537% |
| Phaarmasia Limited | 38.89 Million INR | 204.69% |
| Transchem Limited | -8.96 Million INR | -354.093% |
| Trinity League India Limited | 1.23 Million INR | 3404.708% |
| Tyche Industries Limited | 290.84 Million INR | 113.998% |
| Vista Pharmaceuticals Limited | 10.02 Million INR | 506.327% |
| Zenith Healthcare Limited | 46.17 Million INR | 188.175% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | 321.488% |
| Colinz Laboratories Limited | 16.35 Million INR | 348.939% |
| Denis Chem Lab Limited | 596.24 Million INR | 106.828% |
| Kwality Pharmaceuticals Limited | 1.43 Billion INR | 102.833% |
| Makers Laboratories Limited | 308.54 Million INR | 113.195% |
| Panchsheel Organics Limited | 356.44 Million INR | 111.422% |
| Parnax Lab Limited | 552.1 Million INR | 107.374% |
| PRAVEG LIMITED | 266.99 Million INR | 115.249% |
| Mercury Laboratories Limited | 279.39 Million INR | 114.572% |
| Trident Lifeline Limited | 119.08 Million INR | 134.19% |
| Vikram Thermo (India) Limited | 443.73 Million INR | 109.175% |
| Vivanza Biosciences Limited | 19.38 Million INR | 310.007% |
| Zenlabs Ethica Limited | 147.75 Million INR | 127.555% |
| SHELTER PHARMA LIMITED | 110.97 Million INR | 136.689% |
| Vasundhara Rasayans Limited | 207.68 Million INR | 119.604% |
| Bharat Immunologicals & Biologicals Corporation Limited | -146.67 Million INR | 72.242% |
| Roopa Industries Limited | 72.95 Million INR | 155.809% |
| PANJON LTD. | 33.77 Million INR | 220.531% |
| Pharmaids Pharmaceuticals Limited | -72.81 Million INR | 44.088% |
| TIAAN CONSUMER LIMITED | -17.81 Million INR | -128.602% |
| Anuh Pharma Limited | 1.6 Billion INR | 102.539% |
| Crestchem Limited | 51.53 Million INR | 178.999% |
| Emmessar Biotech & Nutrition Limited | -7.43 Million INR | -447.747% |
| Sandu Pharmaceuticals Limited | 347.1 Million INR | 111.73% |
| Fredun Pharmaceuticals Limited | 724.71 Million INR | 105.618% |
| Trimurthi Limited | 1.95 Million INR | 2186.827% |
| Shukra Pharmaceuticals Limited | 300.38 Million INR | 113.554% |
| Norris Medicines Limited | 29.36 Million INR | 238.661% |
| Veerhealth Care Limited | 49.57 Million INR | 182.128% |
| Lactose (India) Limited | 230.3 Million INR | 117.678% |
| OXYGENTA PHARMACEUTICAL LIMITE | -99.79 Million INR | 59.201% |
| Ambalal Sarabhai Enterprises Limited | 717.63 Million INR | 105.673% |
| Gennex Laboratories Limited | 276.99 Million INR | 114.698% |
| Godavari Drugs Limited | 359.01 Million INR | 111.341% |
| Zenotech Laboratories Limited | 337.19 Million INR | 112.074% |
| Shree Ganesh Remedies Limited | 674.17 Million INR | 106.039% |
| Bharat Parenterals Limited | 989.46 Million INR | 104.115% |
| Coral Laboratories Limited | 332.39 Million INR | 112.249% |
| Evoq Remedies Limited | 47.43 Million INR | 185.833% |
| Kerala Ayurveda Limited | 447.69 Million INR | 109.094% |
| Natural Capsules Limited | 557.1 Million INR | 107.308% |
| Auro Laboratories Limited | 249.39 Million INR | 116.325% |